Abstract
Matrix metalloproteinase-1 (MMP-1) is involved in the degradation of extracellular matrix components and is thought to play a key role in atherogenesis. The objective of the present study was to determine: (1) whether MMP-1 differential gene expression observed in primary cultures of human aortic endothelial cells (HAEC) exposed to cigarette smoke condensate (CSC) was associated with a single nucleotide polymorphism (SNP) in its promoter region and (2) if the SNP altered atherosclerotic lesion development in smokers and nonsmokers. Genotype analysis of six HAEC lines revealed that those homozygous for the 1G-variant exhibited low levels of gene expression. Cells homozygous for the 2G-variant or heterozygous (1G/2G) had elevated levels of both mRNA and protein. These relative levels were also seen after CSC exposure. MMP-1 genotypes of 104 Caucasian males acquired from the Pathobiological Determinants of Atherosclerosis in Youth study were compared with the extent of atherosclerotic lesion development in the aorta. The results indicate that, although the MMP-1 SNP influences MMP-1 gene expression in cultured HAEC exposed to CSC, differences in lesion development were not observed based on this polymorphism in young Caucasian males.
Similar content being viewed by others
References
Cawston, T., Carrere, S., Catterall, J., Duggleby, R., Elliott, S., Shingleton, B., et al. (2001). Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary disease. Novartis Found. Symp. 234:205–218.
Huang, Y., Mironova, M., and Lopes-Virella, M.F. (1999). Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19:2640–2647.
Galis, Z.S., Sukhova, G.K., Lark, M.W., and Libby, P. (1994). Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493–2503.
MacDougall, J.R. and Matrisian, L.M. (1995). Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev. 14:351–362.
Murray, G.I., Duncan, M.E., O’Neil, P., McKay, J.A., Melvin, W.T., and Fothergill, J.E. (1998). Matrix metallo-proteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 185:256–261.
Yoshihara, Y., Nakamura, H., Obata, K., Yamada, H., Hayakawa, T., Fujikawa K., et al. (2000). Matrix metallo-proteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Am. Rheum. Dis. 59:455–461.
Sternlicht, M.D. and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463–516.
Buttice, G., Duterque-Coquillaud, M., Basuyaux, J.P., Carrere, S., Kurkinen, M., and Stehelin, D. (1996). Erg, an Ets-family member, differentially regulates human collagenasel (MMP1) and stromelysin 1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. Oncogene 13:2297–2306.
Rutter, J.L., Mitchell, T.I., Buttice, G., Meyers, J., Gusella, J.F., Ozelius, L.J., et al. (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58:5321–5325.
Benbow, U. and Brinckerhoff C.E. (1997). The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15:519–526.
Liu, Y.Z., Dawson, S.J., Gerster, T., Friedl, E., Pengue, G., Matthias, P., et al. (1996). The ability of the inhibitory domain of the POU family transcription factor Oct-2 to interfere with promoter activation by different classes of activation domains is dependent upon the nature of the basal promoter elements. J. Biol. Chem. 271:20853–20860.
Boyle, D.L., Sajjadi, F.G., and Firestein, G.S. (1996). Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum. 39: 923–930.
Sharrocks, A.D. (2001). The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2:827–837.
Bassuk, A.G. and Leiden, J.M. (1995). A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 3:223–237.
Basuyaux, J.P., Ferreira, E., Stehelin, D., and Buttice, G. (1997). The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and-independent manner. J. Biol. Chem. 272:26188–26195.
Ye, S., Dhillon, S., Turner, S.J., Bateman, A.C., Theaker, J.M., Pickering, R.M., et al. (2001). Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res. 61: 1296–1298.
Ghilardi, G., Biondi, M.L., Mangoni, J., Leviti, S., DeMonti, M., Guagnellini, E., et al. (2001). Matrix metallo-proteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin. Cancer Res. 7: 2344–2346.
Constantin, A., Lauwers-Cances, V., Navaux, F., Abbal, M., van Meerwijk, J., Mazieres, B., et al. (2002). Collagenase-1 (MMP-1) and HLA-DRB1 gene polymorphisms in rheumatoid arthritis: a prospective longitudinal study. J. Rheumatol. 29:15–20.
Katsuda, S., Okada, Y., Minamoto, T., Oda, Y., Matsui, Y., and Nakanishi, I. (1992). Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler. Thromb. 12:494–502.
Davies, M.J. and Thomas, A.C. (1985). Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br. Heart J. 53:363–373.
Falk, E. (1985). Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 71:699–708.
van der Wal, A.C., Becker, A.E., van der Loos, C.M., and Das, P.K. (1994). Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36–44.
Henney, A.M., Wakeley, P.R., Davies, M.J., Foster, K., Hembry, R., Murphy, G., et al. (1991). Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA 88: 8154–8158.
Lee, E., Grodzinsky, A.J., Libby, P., Clinton, S.K., Lark, M.W., and Lee, R.T. (1995). Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. Arterioscler. Thromb. Vasc. Biol. 15: 2284–2289.
Nordskog, B.K., Blixt, A.D., Morgan, W.T., Fields, W.R., and Hellmann, G.M. (2003). Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate. Cardiovasc. Toxicol. 3:101–118.
Hojo, Y., Ikeda, U., Takahashi, M., Sakata, Y., Takizawa, T., Okada, K., et al. (2000). Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells. J. Mol. Cell Cardiol. 32:1459–1468.
Zhu, Y., Hojo, Y., Ikeda, U., Takahashi, M., and Shimada, K. (2000). Interaction between monocytes and vascular smooth muscle cells enhances matrix metalloproteinase-1 production. J. Cardiovasc. Pharmacol. 36:152–161.
Kannel, W.B., McGee, D.L., and Castelli, W.P. (1984). Latest perspectives on cigarette smoking and cardiovascular disease: the Framingham study J. Cardiac Rehabil. 4: 267–277.
US Department of Health and Human Services, Public Health Service, and Office on Smoking and Health. (1993). The health consequences of smoking: cardiovascular disease. A report of the Surgeon General. DHHS Publication (PHS) 84-50204.
Ottesen, M.M., Jorgensen, S., Kjoller, E., Videbaek, J., Kober, L., and Torp-Pedersen, C. (1999). Age-distribution, risk factors and mortality in smokers and non-smokers with acute mycardial infarction: a review. TRACE study group. Danish Trandolapril Cardiac Evaluation. J. Cardiovasc. Risk 6:307–309.
McGill, H.C. Jr., McMahan, C.A., Zieske, A.W., Malcom, G.T., Tracy, R.E., and Strong, J.P. (2001). Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 103:1546–1550.
Diana, J.N. and Vaught, A. (1990). Research cigarettes. Lexington, KY: The University of Kentucky Printing Services.
Bombick, B.R., Murli, H., Avalos, J.T., Bombick, D.W., Morgan, W.T., Putnam, K.P. et al. (1998). Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 2. In vitro toxicology of mainstream smoke condensate. Food Chem. Toxicol. 36:183–190.
Hellmann, G.M., Fields, W.R., and Doolittle, D.J. (2001). Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells. Toxicol. Sci. 61: 154–163.
Hixson, J.E. (1991). Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Arterioscler. Thromb. 11: 1237–1244.
Zhu, Y., Spitz, M.R., Lei, L., Mills, G.B., and Wu, X. (2001). A single nucleotide polymorphism in the matrix metallproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 61:7825–7829.
Rainwater, D.L., McMahan, C.A., Malcom, G.T., Scheer, W.D., Roheim, P.S., McGill, H.C. Jr., et al. (1999). Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group. Arterioscler. Thromb. Vasc. Biol. 19: 753–761.
Wyatt, C.A., Coon, C.I., Gibson, J.J., and Brinckerhoff, C.E. (2002). Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Res. 62:7200–7202.
Ikeda, U., Shimpo, M., Ohki, R., Inaba, H., Takahashi, M., Yamamoto, K., et al. (2000). Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells. Hypertension 36:325–329.
Aikawa, M., Rabkin, E., Okada, Y., Voglic, S.J., Clinton, S.K., Brinckerhoff, C.E., et al. (1998). Lipid lowering by dietreduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97:2433–2444.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nordskog, B.K., Blixt, A.D., Zieske, A.W. et al. MMP-1 polymorphic expression in aortic endothelial cells. Cardiovasc Toxicol 4, 75–83 (2004). https://doi.org/10.1385/CT:4:1:75
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/CT:4:1:75